News

Merit Acquires Biolife Delaware, LLC, Maker of StatSeal^® & WoundSeal^® Medical Device Products

May 20, 2025

“The acquisition of Biolife and the introduction of StatSeal^® and WoundSeal^® products will enhance our ability to deliver comprehensive solutions to our customers and improve patient outcomes.”

— Fred P. Lampropoulos, Merit’s Chairman and Chief Executive Officer

July 18, 2024

Study Demonstrates StatSeal^® efficacy for managing PICC exit site bleeding

August 1, 2023

Investigator-initiated Atrial Fibrillation Study Demonstrates StatSeal^® Efficacy

December 1, 2022

Investigator-initiated Randomized Controlled Trials on Two Continents Indicate Benefits of StatSeal Use

October 1, 2021

1-Hour StatSeal Protocol Safely Shortens Time to Ambulation,
Aiding in Same-Day Discharge

May 6, 2021

Radial Hemostasis Reduced by
50% with StatSeal in Combination
with TR Band

January 28, 2020

Biolife Launches Improved StatSeal^® and WoundSeal^® Products

FOLLOW US!